Langue

Certains contenus peuvent être disponibles uniquement en anglais.

Health Quality Ontario Standards: Opioid Prescribing for Acute Pain

Evidence, Guidelines and Recommendations

This quality standard includes: quality statements, patient reference guide, recommendations for adoption and a getting started guide

Détails

Catégorie
Evidence, Guidelines and Recommendations
Format
Lien Web
Visites
48
Ajouté
25 août 2025
Tags
Psychiatrie
Douleur
Santé mentale
Troubles liés à l'usage de substances
Soins primaires
Médecine interne
Médecine d’urgence

Ressources connexes

Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline
The objective of this guideline is to provide clinical recommendations for the initiation, maintenance and discontinuation of buprenorphine/naloxone maintenance treatment in the ambulatory treatment of adults and adolescents with opioid dependence in Ontario.
Opioid Wisely
Find 15 specialty-specific recommendations for when the use of opioids should not be first line therapy and information resources to help patients have informed conversations with their clinicians about safe options for managing pain.
Recommendations for the use of slow-release oral morphine as opioid agonist therapy
Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT).